- Investigator
- Michael R Bubb
- Status
- Accepting Candidates
Research at a glance
Top areas of exploration
- Actins , 37 publications
- Amino Acid Sequence , 18 publications
- Microfilament Proteins , 18 publications
- Protein Binding , 13 publications
Research activity
Active clinical trials
This study is open to adults aged 18 and older or above legal age who have systemic sclerosis. People can participate if they have a specific subtype called diffuse cutaneous systemic sclerosis. People with another subtype called limited cutaneous…
- Investigator
- Michael R Bubb
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
The purpose of this study is to evaluate long-term safety and tolerability of dapirolizumab pegol treatment.
- Investigator
- Michael R Bubb
- Status
- Accepting Candidates
- Ages
- 16 Years - N/A
- Sexes
- All
My publications
Filter publications
78 publications
2016
Sjögren's syndrome-associated microRNAs in CD14(+) monocytes unveils targeted TGFβ signaling.
Arthritis research & therapy
PubMed • Publisher's site2015
Risk of Disseminated Varicella Zoster in Immunosuppressed Patients Receiving Zoster Vaccination.
Mayo Clinic proceedings
PubMed • Publisher's site2013
Anti-Th/To Antibodies in Various Systemic Rheumatic Diseases Screened By Anti-Rpp25 Elisa.
Arthritis and Rheumatism
2013
Biochemical and biophysical properties of a putative hub protein expressed by vaccinia virus.
The Journal of biological chemistry
PubMed • Publisher's site2012
Clinical Features Associated With Anti-Th/To in Non-Scleroderma Patients - Sine Scleroderma?
Arthritis and Rheumatism